Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $14,978,328 |
Sells | 27 | $4,819,365 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Oct 2023 16:02 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 18 Oct 2023 | Purchase | 979,667 | 10.2076 | 10,000,049 | D |
20 Oct 2023 16:02 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 19 Oct 2023 | Purchase | 384,400 | 10.0608 | 3,867,372 | D |
03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 70,051 | 17.8753 | 1,252,183 | D |
20 Oct 2023 16:02 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 20 Oct 2023 | Purchase | 111,387 | 9.9734 | 1,110,907 | D |
03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 01 May 2024 | Sale | 52,183 | 17.887 | 933,397 | D |
13 Mar 2024 16:24 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 11 Mar 2024 | Sale | 30,000 | 15.2438 | 457,314 | D |
12 Jun 2024 16:29 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 10 Jun 2024 | Sale | 30,000 | 12.6196 | 378,588 | D |
28 Feb 2024 19:55 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 27 Feb 2024 | Sale | 20,000 | 16.1083 | 322,166 | D |
14 May 2024 18:13 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 10 May 2024 | Sale | 10,000 | 16.3743 | 163,743 | D |
03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 03 May 2024 | Sale | 9,154 | 17.852 | 163,417 | D |
22 Apr 2024 18:36 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 18 Apr 2024 | Sale | 10,000 | 16.0163 | 160,163 | D |
26 Mar 2024 18:09 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 25 Mar 2024 | Sale | 10,000 | 16.0055 | 160,055 | D |
03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 03 May 2024 | Sale | 8,078 | 17.8527 | 144,214 | D |
17 May 2024 18:27 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 16 May 2024 | Sale | 7,873 | 16.0787 | 126,588 | D |
20 Feb 2024 18:14 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 16 Feb 2024 | Sale | 7,615 | 15.2481 | 116,114 | D |
17 Nov 2023 18:30 | DAWN | Day One Biopharmaceuticals Inc | DUBOW ADAM | General Counsel | 16 Nov 2023 | Sale | 5,313 | 11.69 | 62,109 | D |
17 May 2024 18:11 | DAWN | Day One Biopharmaceuticals Inc | DUBOW ADAM | GENERAL COUNSEL | 16 May 2024 | Sale | 3,253 | 16.0787 | 52,304 | D |
20 Feb 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | DUBOW ADAM | GENERAL COUNSEL | 16 Feb 2024 | Sale | 3,242 | 15.2481 | 49,434 | D |
17 May 2024 18:15 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 16 May 2024 | Sale | 2,675 | 16.0787 | 43,011 | D |
17 Aug 2023 18:16 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 17 Aug 2023 | Sale | 2,996 | 13.86 | 41,525 | D |
20 Feb 2024 18:36 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 16 Feb 2024 | Sale | 2,666 | 15.2481 | 40,651 | D |
17 May 2024 18:18 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 16 May 2024 | Sale | 2,267 | 16.0787 | 36,450 | D |
17 Nov 2023 18:20 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 16 Nov 2023 | Sale | 3,107 | 11.69 | 36,321 | D |
20 Feb 2024 18:26 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF RESEARCH AND DEVELOPME | 16 Feb 2024 | Sale | 2,258 | 15.2481 | 34,430 | D |
17 Aug 2023 19:02 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 17 Aug 2023 | Sale | 922 | 13.86 | 12,779 | D |
17 Nov 2023 18:33 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 16 Nov 2023 | Sale | 956 | 11.69 | 11,176 | D |
17 Aug 2023 18:21 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | Head of Research and Developme | 17 Aug 2023 | Sale | 668 | 13.86 | 9,258 | D |
17 Nov 2023 18:26 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | Head of Research and Developme | 16 Nov 2023 | Sale | 709 | 11.69 | 8,288 | D |
03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 02 May 2024 | Sale | 200 | 17.8955 | 3,579 | D |
03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 02 May 2024 | Sale | 6 | 17.9375 | 108 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)